...
首页> 外文期刊>Retina >Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy.
【24h】

Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy.

机译:玻璃体腔注射曲安奈德和全视网膜光凝术联合治疗糖尿病性黄斑水肿和增生性糖尿病视网膜病变。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To present our results of intravitreal injection of triamcinolone acetonide (IVTA) combined with panretinal photocoagulation (PRP) for patients with concomitant clinically significant diabetic macular edema and proliferative diabetic retinopathy. METHODS: Charts of patients undergoing combined IVTA and PRP were reviewed. Outcome measures included visual acuity, presence of macular edema, and response of proliferative disease to laser photocoagulation. RESULTS: Four patients were included in this study. All patients maintained stable visual acuity during the treatment period. All patients had improvement in the amount of macular edema, despite the application of PRP, as well as complete regression of their proliferative disease. There were no short-term complications associated with IVTA or PRP. CONCLUSION: Combination treatment with IVTA and PRP may provide benefit in patients with diffuse diabetic macular edema who require urgent PRP for proliferative diabetic retinopathy by preventing exacerbation of macular edema.
机译:目的:介绍玻璃体腔注射曲安奈德(IVTA)联合全视网膜光凝(PRP)治疗伴有临床上重要的糖尿病性黄斑水肿和增生性糖尿病视网膜病变的患者的结果。方法:回顾了接受IVTA和PRP联合治疗的患者图表。结果指标包括视敏度,黄斑水肿的存在以及增生性疾病对激光光凝的反应。结果:本研究纳入4例患者。所有患者在治疗期间均保持稳定的视力。尽管应用了PRP,但所有患者的黄斑水肿程度均得到改善,并且其增生性疾病完全消退。没有IVTA或PRP相关的短期并发症。结论:IVTA和PRP联合治疗可为弥漫性糖尿病性黄斑水肿患者提供益处,可通过预防黄斑水肿的加重而为增生性糖尿病性视网膜病急需PRP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号